Does BENDAMUSTINE Cause Post transplant lymphoproliferative disorder? 29 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 29 reports of Post transplant lymphoproliferative disorder have been filed in association with BENDAMUSTINE (VIVIMUSTA). This represents 0.2% of all adverse event reports for BENDAMUSTINE.
29
Reports of Post transplant lymphoproliferative disorder with BENDAMUSTINE
0.2%
of all BENDAMUSTINE reports
13
Deaths
14
Hospitalizations
How Dangerous Is Post transplant lymphoproliferative disorder From BENDAMUSTINE?
Of the 29 reports, 13 (44.8%) resulted in death, 14 (48.3%) required hospitalization, and 6 (20.7%) were considered life-threatening.
Is Post transplant lymphoproliferative disorder Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BENDAMUSTINE. However, 29 reports have been filed with the FAERS database.
What Other Side Effects Does BENDAMUSTINE Cause?
Off label use (2,578)
Disease progression (2,456)
Pyrexia (1,322)
Neutropenia (1,256)
Drug ineffective (1,135)
Febrile neutropenia (1,005)
Pneumonia (975)
Thrombocytopenia (967)
Covid-19 (892)
Anaemia (817)
What Other Drugs Cause Post transplant lymphoproliferative disorder?
TACROLIMUS (2,529)
MYCOPHENOLATE MOFETIL (1,762)
PREDNISONE (1,441)
CYCLOSPORINE (957)
PREDNISOLONE (772)
RITUXIMAB (719)
CYCLOPHOSPHAMIDE (667)
METHYLPREDNISOLONE (506)
LAPINE T-LYMPHOCYTE IMMUNE GLOBULIN (439)
MYCOPHENOLIC ACID (438)
Which BENDAMUSTINE Alternatives Have Lower Post transplant lymphoproliferative disorder Risk?
BENDAMUSTINE vs BENDROFLUMETHIAZIDE
BENDAMUSTINE vs BENIDIPINE
BENDAMUSTINE vs BENLYSTA
BENDAMUSTINE vs BENRALIZUMAB
BENDAMUSTINE vs BENSERAZIDE